Morrison Foerster Named Healthcare and Life Sciences Law Firm of the Year at the ALB Japan Law Awards 2023

Morrison Foerster was named Healthcare and Life Sciences Law Firm of the Year at the 19th annual Asian Legal Business (ALB) Japan Law Awards 2023. The awards honor the achievements of Japan’s leading private practice law firms, in-house teams, and individual practitioners.

Morrison Foerster’s life sciences offering is unrivalled and no international firm in Japan can match the depth of MoFo’s practice. From concept to commercialization and through exit, our Life Sciences Practice’s business is able to provide the full scope of services, with broad strength across a variety of practice areas including corporate/M&A, litigation, technology transactions, IP, compliance & investigations, and capital markets. In the past decade, Morrison Foerster has represented over 250 of the largest and most active participants in the Japanese life sciences industry including emerging and established Japanese companies and active international clients. The firm counts among its clients some of the leading names in the biopharma and healthcare industries and some of the fastest growing companies in the life sciences sector.

Further to these wins, Morrison Foerster was a finalist across several other firm and deal categories. These include in the Technology, Media, and Telecommunications Law Firm of the Year category, two separate deals in the Debt Market Deal of the Year category and being named a finalist in the M&A Deal of the Year (Premium) and the Real Estate Deal of the Year categories.

View the full list of 2023 ALB Japan Award winners on the publication’s website.